These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36301125)

  • 1. Liver fibrosis in young patients with transfusion-dependent thalassaemia (TDT), understanding the role of steatosis.
    Ricchi P
    Br J Haematol; 2023 Feb; 200(4):399-400. PubMed ID: 36301125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients.
    Padeniya P; Ediriweera D; De Silva AP; Niriella M; Premawardhena A
    Br J Haematol; 2023 Feb; 200(4):517-523. PubMed ID: 36194160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion-dependent thalassaemia.
    Padeniya P; Premawardhena A
    Br J Haematol; 2024 Jul; 205(1):28-29. PubMed ID: 38744440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver steatosis in patients with transfusion-dependent thalassaemia.
    Ricchi P; Pistoia L; Positano V; Spasiano A; Casini T; Putti MC; Borsellino Z; Cossu A; Messina G; Keilberg P; Fatigati C; Costantini S; Renne S; Peritore G; Cademartiri F; Meloni A
    Br J Haematol; 2024 Jun; 204(6):2458-2467. PubMed ID: 38685724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.
    Elalfy MS; Esmat G; Matter RM; Abdel Aziz HE; Massoud WA
    Ann Hepatol; 2013; 12(1):54-61. PubMed ID: 23293194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
    Ricchi P; Meloni A; Spasiano A; Costantini S; Pepe A; Cinque P; Filosa A
    Br J Haematol; 2018 Mar; 180(5):721-726. PubMed ID: 29363758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.
    Walter PB; Fung EB; Killilea DW; Jiang Q; Hudes M; Madden J; Porter J; Evans P; Vichinsky E; Harmatz P
    Br J Haematol; 2006 Oct; 135(2):254-63. PubMed ID: 17010049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition.
    Di Marco V; Bronte F; Cabibi D; Calvaruso V; Alaimo G; Borsellino Z; Gagliardotto F; Almasio PL; Capra M; Craxì A
    Br J Haematol; 2010 Feb; 148(3):476-9. PubMed ID: 19930183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Chelation Therapy as a Modality of Management.
    Aydinok Y
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of cytochrome P450 1A2 in relation to hepatic iron accumulation in transfusion-dependent β-thalassaemia major patients.
    Shteyer E; Nitzan I; Godfarb A; Hemed N; Revel-Vilk S
    Vox Sang; 2015 Apr; 108(3):268-73. PubMed ID: 25471486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.
    Angelucci E; Muretto P; Nicolucci A; Baronciani D; Erer B; Gaziev J; Ripalti M; Sodani P; Tomassoni S; Visani G; Lucarelli G
    Blood; 2002 Jul; 100(1):17-21. PubMed ID: 12070002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient elastography in the assessment of liver fibrosis in adult thalassemia patients.
    Fraquelli M; Cassinerio E; Roghi A; Rigamonti C; Casazza G; Colombo M; Massironi S; Conte D; Cappellini MD
    Am J Hematol; 2010 Aug; 85(8):564-8. PubMed ID: 20658587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
    Zekavat OR; Zareian Jahromi M; Haghpanah S; Kargar Jahromi Z; Cohan N
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e26-e28. PubMed ID: 32925401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases.
    Prati D; Maggioni M; Milani S; Cerino M; Cianciulli P; Coggi G; Forni GL; Magnano C; Meo A; Gramignoli R; Rebulla P; Fiorelli G; Cappellini MD;
    Haematologica; 2004 Oct; 89(10):1179-86. PubMed ID: 15477201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.
    Ladis V; Berdousi H; Gotsis E; Kattamis A
    Br J Haematol; 2010 Dec; 151(5):504-8. PubMed ID: 20950401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.
    Gamberini MR; Francesconi R; Fortini M; Cavazzini L; Lari F; Scapoli C; Ballardini G; De Sanctis V; Bianchi FB
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():259-66. PubMed ID: 16462707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
    Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
    Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.